Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000495935 | SCV002817139 | uncertain significance | Hypercholesterolemia, familial, 1 | 2022-08-29 | reviewed by expert panel | curation | The NM_000527.5(LDLR):c.1221C>T (p.His407=) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying evidence codes (PM2, BP4, BP7) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1101/2021.03.17.21252755). The supporting evidence is as follows: PM2 - This variant is absent from gnomAD (gnomAD v2.1.1). BP4 - No REVEL, splicing evaluation required. Functional data not available A) not on limits B) does not create AG Variant not predicted to alter splicing BP7 - Variant is synonymous and meets BP4. |
U4M - |
RCV000495935 | SCV000583808 | uncertain significance | Hypercholesterolemia, familial, 1 | 2024-10-23 | criteria provided, single submitter | clinical testing | Additional comments to ClinGen Familial Hypercholesterolemia Variant Curation Expert Panel ClinGen - FDA RECOGNIZED DATABASE (accession SCV002817139.1) of insufficient evidence for Familial Hypercholesterolemia by applying evidence codes (PM2, BP4, BP7). New evidence has been collected since original submission in 2017: lack of segregation with hypercholesterolemia in one family (BS4). This variant was observed in trans with distinct pathogenic variants at the LDLR locus, in two independent families (BP2). Therefore this variant is now classified as variant of Uncertain significance. |
Color Diagnostics, |
RCV000776579 | SCV000912192 | likely benign | Familial hypercholesterolemia | 2018-07-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000776579 | SCV002413978 | likely benign | Familial hypercholesterolemia | 2024-04-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356810 | SCV002655440 | likely benign | Cardiovascular phenotype | 2024-12-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000495935 | SCV000606365 | benign | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research |